Page last updated: 2024-10-22

aminoglutethimide and Syndrome

aminoglutethimide has been researched along with Syndrome in 3 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Syndrome: A characteristic symptom complex.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harinck, HI1
van Brummelen, P1
Van Seters, AP1
Moolenaar, AJ1
Rodríguez, JA1
Fabre, JF1
Pourreau-Schneider, N1
Martin, PM1
Puissant, A1

Other Studies

3 other studies available for aminoglutethimide and Syndrome

ArticleYear
Apparent mineralocorticoid excess and deficient 11 beta-oxidation of cortisol in a young female.
    Clinical endocrinology, 1984, Volume: 21, Issue:5

    Topics: Adrenocorticotropic Hormone; Adult; Alkalosis; Amiloride; Aminoglutethimide; Dexamethasone; Drug The

1984
[Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
    Revista medica de Chile, 2000, Volume: 128, Issue:1

    Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adolescent; Aminoglutethimide; Blood Pressure; Body Hei

2000
[Dosage and modulation of cutaneous steroid receptors during antihormonal therapy in a case of Stewart-Treves syndrome].
    Annales de dermatologie et de venereologie, 1988, Volume: 115, Issue:10

    Topics: Adenocarcinoma; Aged; Aminoglutethimide; Breast Neoplasms; Female; Humans; Immunoenzyme Techniques;

1988